These results indicate that LIGc markedly suppresses the inflammatory response in the cerebral cortex of mice with neuroinflammation and ischemic stroke by modulating the FPR1/NLRP3 signaling pathway, thereby ameliorating their neurological deficits and disease progression. The gene discussed is FPR1; the disease is ischemic stroke.